Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has developed a multifunctional Covert-Hologram Seal that offers first-opening indication and tamper evidence, plus counterfeiting protection. The seal features an irreversible, holographic effect, and complies with the Falsified Medicines Directive 2011/62/EU that will be enforced beginning February 2019. The Directive requires all pharmaceutical manufacturers to mark their prescription medicine...